Table 1.

Baseline characteristics of study participants (n = 63)

Variable	Data	Min-max	Normal range	F/M
Age, years	40 ± 11	20–63	–	ns
Weight, kg	77.1 ± 13.3	51–120	–	70 ± 10 / 83 ± 13**
Height, m	1.67 ± 0.09	1.50–1.87	–	1.60 ± 0.07 / 1.73 ± 0.06**
BMI, kg/m2	27.6 ± 4.2	19.6–40.1	–	ns
WC, m	0.97 ± 0.12	0.75–1.24	–	ns
SBP, mm Hg	134 ± 15	103–177	<130	127 ± 13 / 140 ± 14**
DBP, mm Hg	80 ± 10	61–107	<85	ns
Glycemia, mg/dl	86 ± 9	67–115	70–105	ns
HbA1c, %	5.2 ± 0.3	4.5–5.8	3.8–5.6	ns
TC, mg/dl	194 ± 36	117–283	0–200	ns
HDL-C, mg/dl	50 ± 15	25–91	35–55	57 ± 15 / 45 ± 12*
LDL-C, mg/dl	123 ± 33	60–209	0–130	ns
VLDL-C, mg/dla	19 (13–25)	6–58	3–56	15 (10–20) / 23 (15–28)*
TAG, mg/dla	94 (67–124)	32–475	40–160	75 (51–99)/116 (76–140)*
NA, pmol/la	690 (395–1,552)	40–3,760	709–4019	ns
AD, pmol/la	154 (81–227)	55–965	<328	151 (81–185)/163 (103–279)*
Cortisol, μg/dla	15 (13–18)	6.4–28.4	6.2–19.4	ns
Leptin, ng/mla, b	0.63 (0.28–1.10)	0.003–5.3	2–5.6	1.05 (0.70–2.09)/0.31 (0.10–0.50)**
hsCRP, mg/la, c	1.460 (0.617–3.015) 0.150–17.800	<1.0 low risk	ns
			1.0 to <3.0 intermediate risk
			>3.0 high risk
Leukocytes, cells/μl	6,494 ± 1,585	3,500–11,600 4,500–13,000	ns
Monocytes, cells/µl	439 ± 157	82–964	400–500	384 ± 107 / 483 ± 177*
CD14 expression ratio 0.40 ± 0.17	0.14–0.87	–	0.35 ± 0.14 / 0.44 ± 0.17*
(CD16+/CD16−monocytes)

ns = Nonsignificant; F/M = female/male ratio (=28/35).

Data are shown as mean ± SD for normally distributed data. ANOVA and non-parametric Mann-Whitney test was used to compare quantitative independent variables by gender for normally and non-normally distributed data, respectively.

^aNon-parametric data as median (interquartile range); or percentage as appropriate.

^bn=41.

^cn = 60.

^*p < 0.05

^**= p 7lt; 0.001.